Sanofi - Aventis Groupe: Press Release: Sanofi cuts U.S. lis

Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance Paris, March 16, 2023. Sanofi announces

Related Keywords

Paris , France General , France , Dennis Riedl , Eva Schaefer Jansen , Corentine Driancourt , Evan Berland , Felix Lauscher , Tarik Elgoutni , Nathalie Pham , Sandrine Guendoul , Olivier Bogillot , Centers For Medicare , Insulins Valyou Savings Program , Medicaid Service , Nasdaq , Euronext , Savings Program , Sanofi Patient Connection , Inflation Reduction Act , Medicare Part , Senior Savings Model , Principles Report , Private Securities Litigation Reform Act , Statement Regarding Forward Looking , Sanofi , Eventis , Roupe , Dress , Release , Cuts , Mist , Price , Lantus , Most , Unprescribed , Insulin , Caps , Rocket , Costs , Patients , Commercial , Insurance ,